FGH BioTech
FGH BioTech is a preclinical-stage biotechnology company focused on discovery and development of small-molecule therapeutics that modulate SREBP transcription factors and related lipid metabolism pathways for metabolic diseases and certain cancers. The company was founded in 2011 via an academic technology license and builds on decades of foundational research in fatty acid metabolism.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Small Molecule Drugs Regulating SREBP Transcription Factors
Small molecule drugs developed to regulate SREBP transcription factors and related pathways for treating metabolic diseases and cancer.
Small Molecule Drugs Regulating SREBP Transcription Factors
Small molecule drugs developed to regulate SREBP transcription factors and related pathways for treating metabolic diseases and cancer.
Expertise Areas
- Small-molecule drug discovery
- Preclinical pharmacology and efficacy testing
- Metabolic disease therapeutics (fatty liver, diabetes, cardiovascular risk)
- Oncology therapeutics targeting lipid metabolism
Key Technologies
- Modulation of SREBP transcription factors
- Small-molecule medicinal chemistry
- In vitro biochemical and cell-based assays
- Diet-induced and genetic mouse models
News & Updates
Publication on the structural organization of animal fatty acid synthase.
Review or article discussing fatty acid metabolism as a target for metabolic syndrome.
Study reporting metabolic phenotype of ACC2 knockout mice.
Company founded in 2011 through a technology transfer license agreement from an academic institution.
A founding scientist was elected to the National Academy of Sciences.
Recognition listed among the founders' awards.
Publication on the structural organization of animal fatty acid synthase.
Review or article discussing fatty acid metabolism as a target for metabolic syndrome.
Study reporting metabolic phenotype of ACC2 knockout mice.
Company founded in 2011 through a technology transfer license agreement from an academic institution.
A founding scientist was elected to the National Academy of Sciences.
Recognition listed among the founders' awards.